StockData
Incannex Healthcare Inc. logo

Incannex Healthcare Inc. (IXHL) stock

IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.74−0.19 (-9.84%)

Close on Nov 17, 2026Market cap $21.83MP/E –Yield –

Incannex Healthcare cash

Cash and short-term investments held at the end of each period.

Incannex Healthcare's cash was $68.27M at Sep 30, 2026. For fiscal 2026 it was $67.71M, up 350.2% from the year before. The highest annual figure on record is $67.71M in fiscal 2026.

Annual cash

PeriodPeriod endValueChange
FY2026Jun 30, 2026$67.71M+350.2%
FY2025Jun 30, 2025$15.04M+156.7%
FY2024Jun 30, 2024$5.86M-73.5%
FY2023Jun 30, 2023$22.12M-14.4%
FY2022Jun 30, 2022$25.83M+183.2%
FY2021Jun 30, 2021$9.12M+153.2%
FY2020Jun 30, 2020$3.60M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$68.27M-6.8%
Q4 FY2026CQ2 2026Jun 30, 2026$67.71M+350.2%
Q3 FY2026CQ1 2026Mar 31, 2026$74.45M+1009.4%
Q2 FY2026CQ4 2025Dec 31, 2025$68.90M+3184.1%
Q1 FY2026CQ3 2025Sep 30, 2025$73.28M+1920.4%
Q4 FY2025CQ2 2025Jun 30, 2025$15.04M+156.7%
Q3 FY2025CQ1 2025Mar 31, 2025$6.71M-28.1%
Q2 FY2025CQ4 2024Dec 31, 2024$2.10M-85.6%
Q1 FY2025CQ3 2024Sep 30, 2024$3.63M-77.7%
Q4 FY2024CQ2 2024Jun 30, 2024$5.86M-73.5%
Q3 FY2024CQ1 2024Mar 31, 2024$9.34M-62.5%
Q2 FY2024CQ4 2023Dec 31, 2023$14.56M-48.1%
Q1 FY2024CQ3 2023Sep 30, 2023$16.28M-37.0%
Q4 FY2023CQ2 2023Jun 30, 2023$22.12M+11.9%
Q3 FY2023CQ1 2023Mar 31, 2023$24.88M+172.7%
Q2 FY2023CQ4 2022Dec 31, 2022$28.07M+678.8%
Q4 FY2022CQ2 2022Jun 30, 2022$25.83M–
Q2 FY2022CQ4 2021Dec 31, 2021$19.77M–
Q4 FY2021CQ2 2021Jun 30, 2021$9.12M–
Q4 FY2020CQ2 2020Jun 30, 2020$3.60M–

More Incannex Healthcare figures

See a number that looks wrong?